BIOMAT Database Logo BIOMAT Database Logo

Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase. 1989

G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Department of Medicinal Chemistry, University of Kansas, Lawrence 66045.

The conformational and steric aspects of binding to phenylethanolamine N-methyltransferase (PNMT; EC 2.1.1.28) for phenylethanolamine substrates and phenylethylamine inhibitors were probed with three conformationally defined analogues (11, 12, and 13) of phenylethylamine (1) and phenylethanolamine (6) containing the benzobicyclo[3.2.1]octane skeleton. The 2-aminotetralin (2AT) moiety in conformationally defined analogues 11, 12, and 13 exists in a half-chair conformation with an equatorial amino group. Although conformationally restricted phenylethylamine analogue 2AT (3, Ki = 6.8 microM) and conformationally restricted phenylethanolamine analogues (cis)- and (trans)-2-amino-1-tetralol (9, Km = 22 microM; Vmax = 0.15; 100 X Vmax/Km = 0.68; 10, Ki = 9.4 microM) are good ligands for PNMT, none of the analogues 11, 12, and 13 showed activity as a substrate of PNMT. The fact that 11 (Ki = 206 microM) is more potent than analogues 4 (Ki = 1296 microM) and 5 (Ki = 479 microM), with a half-boat 2AT moiety, suggests that PNMT preferentially binds the half-chair conformation of 2AT at the active site. This is consistent with previous findings that a fully extended conformation for the aminoethyl side chain of phenylethylamine inhibitors is optimal for PNMT binding. The reduced activity of 11, 12 (Ki = 1246 microM), and 13 (Ki = 3000 microM), compared with 2AT and (cis)- and (trans)-2-amino-1-tetralol (9 and 10) is consistent with a negative steric interference from the extra ethano bridge in 11, 12, and 13. The results from 11, 12, and 13, combined with previous findings, suggest that PNMT interacts better with relatively planar ligands.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D010625 Phenylethanolamine N-Methyltransferase A methyltransferase that catalyzes the reaction of S-adenosyl-L-methionine and phenylethanolamine to yield S-adenosyl-L-homocysteine and N-methylphenylethanolamine. It can act on various phenylethanolamines and converts norepinephrine into epinephrine. (From Enzyme Nomenclature, 1992) EC 2.1.1.28. Phenethanolamine N-Methyltransferase,Noradrenalin N-Methyltransferase,Noradrenaline N-Methyltransferase,Norepinephrine Methyltransferase,Norepinephrine N-Methyltransferase,Methyltransferase, Norepinephrine,Noradrenalin N Methyltransferase,Noradrenaline N Methyltransferase,Norepinephrine N Methyltransferase,Phenethanolamine N Methyltransferase,Phenylethanolamine N Methyltransferase
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015078 2-Hydroxyphenethylamine Simple amine found in the brain. It may be modulator of sympathetic functions. Its derivatives are adrenergic agonists and antagonists. It is also used in chemical industry. 2-Phenylethanolamine,Bisnorephedrine,beta-Hydroxyphenethylamine,beta-Phenylethanolamine,2 Hydroxyphenethylamine,2 Phenylethanolamine,beta Hydroxyphenethylamine,beta Phenylethanolamine

Related Publications

G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Conformational and steric aspects of the inhibition of phenylethanolamine N-methyltransferase by benzylamines.
February 1988, Journal of medicinal chemistry,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Importance of the aromatic ring in adrenergic amines. 5. Nonaromatic analogues of phenylethanolamine as inhibitors of phenylethanolamine N-methyltransferase: role of hydrophobic and steric interactions.
January 1981, Journal of medicinal chemistry,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Importance of the aromatic ring in adrenergic amines. 6. Nonaromatic analogues of phenylethanolamine as inhibitors of phenylethanolamine N-methyltransferase: role of pi-electronic and steric interactions.
January 1981, Journal of medicinal chemistry,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Conformational preference for the binding of biaryl substrates and inhibitors to the active site of phenylethanolamine N-methyltransferase.
January 1988, Journal of medicinal chemistry,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Transition-State Analogues of Phenylethanolamine N-Methyltransferase.
August 2020, Journal of the American Chemical Society,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Synthesis and evaluation of 3-substituted analogues of 1,2,3,4-tetrahydroisoquinoline as inhibitors of phenylethanolamine N-methyltransferase.
April 1988, Journal of medicinal chemistry,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
The binding order of substrates to phenylethanolamine N-methyltransferase.
November 1973, Molecular pharmacology,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Quantitative structure-activity relationship studies of non-aromatic analogues of ethanolamine as inhibitors of phenylethanolamine N-methyltransferase.
January 1985, Arzneimittel-Forschung,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
Conformational preferences of amphetamine analogues for inhibition of phenylethanolamine N-methyltransferase. Conformationally defined adrenergic agents. 5.
September 1981, Molecular pharmacology,
G L Grunewald, and Q Ye, and D J Sall, and K R Criscione, and B Wise
[Phenylethanolamine N-methyltransferase].
November 2004, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!